Health Minister Frank Vandenbroucke has ended reimbursement of Mounjaro as an obesity drug in Belgium. The Brussels Times has the details.
Recap by typeshit. Full story at The Brussels Times.
A TV segment airing on WSIL and KFVS looks at the weight loss drug trend and what coverage people might be able to get through their insurance today.
Monthly units climbed from 114,000 in February to 434,000 in September, and sales value rose from ₹48 cr to ₹113 cr as doctors report wider access.
Lilly is lowering what it charges for one of its weight loss drugs. The headline doesn't say which drug or by how much.
Access to Ozempic, Wegovy and Mounjaro in Australia often comes down to who can pay, raising the question of public subsidies.
Obesity specialist Beverly Tchang posts her top three takeaways on the science of amylin based drugs after speaking at an AAFP event.
His family says his BMI fell from 36 to 22.8 over two years on Wegovy, and he has since joined a cheer team. His doctor says the drug isn't right for every child.
Loading…